Validation of Young thinking and reasoning skills training package and comparison of its effectiveness with Pars empowerment training package on selective attention problems, mood instability, impulsivity, perception of social competence and symptoms of ADHD

Validation of Young's Thinking and Argumentation Skills Curriculum Package and Comparing Its Effectiveness with the Pars's Power-Generating Educational Package on the Problems and Selective Attention , Mood Instability ,Impulsivity , Social Competence Perception in Children Aged 8-12 Years Old Attention Deficit - Hyperactivity in the Primary School

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220604055075N1

Enrollment

Registered

2022-12-19

Start date

2020-10-30

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit / hyperactivity disorder. Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention 1: The first intervention group: Yang's thinking and reasoning skills training package (8 sessions of 2 hours). Intervention 2: The second intervention group: Pars 8 empowerment training

Eligibility

Sex/Gender

All

Age

8 Years to 12 Years

Inclusion criteria

Inclusion criteria: The candidate's complete agreement to engage in the study Age range 8 to 12 years Not being participated in other treatment programs at the same time and obtaining individual counseling and medication Existence of accompanying psychiatric disorders Use a regular medication regimen Diagnosing Attention Deficit Hyperactivity Disorder combined sub-type by psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders

Exclusion criteria

Exclusion criteria: Existing comorbid psychiatric disorders such as autism spectrum disorder, learning disorders, and so on. regular use of medication except for Methylphenidate

Design outcomes

Primary

Measure	Time frame
Perception of social competence. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Social Competence Perception Questionnaire.;Mood instability. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Mood instability questionnaire.;Impulsivity. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Bart's Impulse Scale.;Selective attention problems. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Test word and color strops.;Symptoms of hyperactivity disorder. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Attention Deficit Hyperactivity Disorder Questionnaire.	—

Measure

Time frame

Perception of social competence. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Social Competence Perception Questionnaire.;Mood instability. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Mood instability questionnaire.;Impulsivity. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Bart's Impulse Scale.;Selective attention problems. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Test word and color strops.;Symptoms of hyperactivity disorder. Timepoint: Before the intervention and the following week and three months after the intervention. Method of measurement: Attention Deficit Hyperactivity Disorder Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMiad Seifipour

Islamic Azad University

miad.seifipour@gmail.com+98 21 5573 5961

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026